Sovaldi

DRUG3 trials

Sponsors

Genuine Research Center, Egypt, Gilead Sciences

Conditions

HCV InfectionHealthy

Phase 1

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

CompletedNCT02491450

Genuine Research Center, EgyptHealthy

Start: 2015-02-28End: 2015-02-28Updated: 2015-07-08

A Bio-equivalence Study of Sofosbuvir From Elbanovir 400 mg Film Coated Tablets ( Multi-Apex Pharma, Egypt) & Sovaldi 400 mg Film Coated Tablets (Gilead Sciences, United Kingdom)

CompletedNCT02605798

Genuine Research Center, EgyptHealthy

Start: 2015-08-31End: 2015-10-31Updated: 2015-11-16

Unknown Phase

Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice

CompletedNCT02783976

Gilead SciencesHCV Infection

Start: 2016-10-28End: 2018-06-20Updated: 2018-10-02